Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Böll, Boris  [Clear All Filters]
2014
Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T, Klimm B, Diehl V, Sasse S, Rothe A, et al. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood. 2014.
2022
Gillessen S, Pluetschow A, Vucinic V, Ostermann H, Kobe C, Bröckelmann PJ, Böll B, Eichenauer DA, Heger J-M, Borchmann S, et al. JAK Inhibition with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: Final Results of A Phase II, Open Label, Multicenter Clinical Trial (JeRiCHO). Eur J Haematol. 2022.
2023
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup J-H, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, et al. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis. Eur J Haematol. 2023.
Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup J-H, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E. Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry. Infection. 2023.
Beutel G, Liebregts T, Böll B. [With a tumor diagnosis in the intensive care unit]. Inn Med (Heidelb). 2023.